Company intelligence / Profile preview

Transdermal Research Pharm Laboratories

Long Island City, New York, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~6
Development stage: Phase 1

Overview

TRPL specializes in the development of topical and transdermal drug delivery systems. The company has developed over 15 drug molecules in transdermal formulations ranging from once-daily to seven-day patches. They offer expertise in both in vitro percutaneous absorption studies and in vivo models to expedite product development for clients. Their facility includes state-of-the-art R&D labs with plans for GMP certification.

Therapeutic areas: Other
Modalities: Small moleculeDeviceBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Transdermal Research Pharm Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transdermal Research Pharm Laboratories.

Explore the full profile